Ledger.Open graph →
SEC Form D · filed July 1, 2025

Sparrow Pharmaceuticals, Inc

Offering
$121.4M
Sold
$61.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PORTLAND, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jonathan Root · Maple Grove, MNDirectorNiall O'Donnell · San Diego, CADirectorZach Scheiner · Del Mar, CADirectorKlaus Veitinger · New York, NYDirectorNanna L?Neborg · Portland, ORDirectorPeter Thompson · Seattle, WADirectorRobert Jacks · Portland, ORExec · DirectorJonathan Root · San Francisco, CADirectorNiall O'Donnell · San Diego, CADirectorZach Scheiner · Del Mar, CADirectorKlaus Veitinger · Newark, NJDirectorNanna L?Neborg · Portland, ORDirectorPeter Thompson · New York, NYDirectorRobert Jacks · Newark, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗